|
Search for our Investigators on Pub
Med
|
Kim E. Creek , PhD Lab
LAB PERSONNEL
Kim Creek, Ph.D. Assistant Professor, USC
PUBLICATIONS
Ohashi Y, Creek KE, Pirisi L, Kalus R, Young SR. RNA
degradation in human breast tissue after surgical removal: a
time-course study. Exp Mol Pathol. 2004 Oct;77(2):98-103.
Baldwin A, Pirisi L, Creek KE. NFI-Ski interactions mediate
transforming growth factor beta modulation of human
papillomavirus type 16 early gene expression. J Virol. 2004
Apr;78(8):3953-64.
Walters JJ, Muhammad W, Fox KF, Fox A, Xie D, Creek KE,
Pirisi L. Genotyping single nucleotide polymorphisms using
intact polymerase chain reaction products by electrospray
quadrupole mass spectrometry. Rapid Commun Mass Spectrom.
2001;15(18):1752-9.
Akerman GS, Tolleson WH, Brown KL, Zyzak LL, Mourateva E,
Engin TS, Basaraba A, Coker AL, Creek KE, Pirisi L. Human
papillomavirus type 16 E6 and E7 cooperate to increase
epidermal growth factor receptor (EGFR) mRNA levels,
overcoming mechanisms by which excessive EGFR signaling
shortens the life span of normal human keratinocytes. Cancer
Res. 2001 May 1;61(9):3837-43.
Krahmer MT, Walters JJ, Fox KF, Fox A, Creek KE, Pirisi L,
Wunschel DS, Smith RD, Tabb DL, Yates JR 3rd. MS for
identification of single nucleotide polymorphisms and MS/MS
for discrimination of isomeric PCR products. Anal Chem. 2000
Sep 1;72(17):4033-40.
Xu X, Kelleher KF, Liao J, Creek KE, Pirisi L. Unique
carboxyl-terminal sequences of wild type and alternatively
spliced variant forms of transforming growth factor-alpha
precursors mediate specific interactions with ErbB4 and
ErbB2. Oncogene. 2000 Jun 29;19(28):3172-81.
Mi Y, Borger DR, Fernandes PR, Pirisi L, Creek KE. Loss of
transforming growth factor-beta (TGF-beta) receptor type I
mediates TGF-beta resistance in human papillomavirus type
16-transformed human keratinocytes at late stages of in
vitro progression. Virology. 2000 May 10;270(2):408-16.
Borger DR, Mi Y, Geslani G, Zyzak LL, Batova A, Engin TS,
Pirisi L, Creek KE. Retinoic acid resistance at late stages
of human papillomavirus type 16-mediated transformation of
human keratinocytes arises despite intact retinoid signaling
and is due to a loss of sensitivity to transforming growth
factor-beta. Virology. 2000 May 10;270(2):397-407.
Xie D, Shu XO, Deng Z, Wen WQ, Creek KE, Dai Q, Gao YT, Jin
F, Zheng W. Population-based, case-control study of HER2
genetic polymorphism and breast cancer risk. J Natl Cancer
Inst. 2000 Mar 1;92(5):412-7.
Xu X, Liao J, Creek KE, Pirisi L. Human keratinocytes and
tumor-derived cell lines express alternatively spliced forms
of transforming growth factor-alpha mRNA, encoding
precursors lacking carboxyl-terminal valine residues.
Oncogene. 1999 Sep 30;18(40):5554-62.
Hodam JR, Creek KE. Comparison of the metabolism of retinol
delivered to human keratinocytes either bound to serum
retinol-binding protein or added directly to the culture
medium. Exp Cell Res. 1998 Jan 10;238(1):257-64.
Khan MA, Canhoto AJ, Housley PR, Creek KE, Pirisi L.
Glucocorticoids stimulate growth of human papillomavirus
type 16 (HPV16)-immortalized human keratinocytes and support
HPV16-mediated immortalization without affecting the levels
of HPV16 E6/E7 mRNA. Exp Cell Res. 1997 Oct
10;236(1):304-10.
Godwin DA, Michniak BB, Creek KE. Evaluation of transdermal
penetration enhancers using a novel skin alternative. J
Pharm Sci. 1997 Sep;86(9):1001-5.
Hodam JR, Creek KE. Uptake and metabolism of [3H]retinoic
acid delivered to human foreskin keratinocytes either bound
to serum albumin or added directly to the culture medium.
Biochim Biophys Acta. 1996 Apr 24;1311(2):102-10.
Creek KE, Geslani G, Batova A, Pirisi L. Progressive loss of
sensitivity to growth control by retinoic acid and
transforming growth factor-beta at late stages of human
papillomavirus type 16-initiated transformation of human
keratinocytes. Adv Exp Med Biol. 1995;375:117-35.
Zyzak LL, MacDonald LM, Batova A, Forand R, Creek KE, Pirisi
L. Increased levels and constitutive tyrosine
phosphorylation of the epidermal growth factor receptor
contribute to autonomous growth of human papillomavirus type
16 immortalized human keratinocytes. Cell Growth Differ.
1994 May;5(5):537-47.
Creek KE, Jenkins GR, Khan MA, Batova A, Hodam JR, Tolleson
WH, Pirisi L. Retinoic acid suppresses human papillomavirus
type 16 (HPV16)-mediated transformation of human
keratinocytes and inhibits the expression of the HPV16
oncogenes. Adv Exp Med Biol. 1994;354:19-35.
Khan MA, Jenkins GR, Tolleson WH, Creek KE, Pirisi L.
Retinoic acid inhibition of human papillomavirus type
16-mediated transformation of human keratinocytes. Cancer
Res. 1993 Feb 15;53(4):905-9.
Creek KE, St Hilaire P, Hodam JR. A comparison of the
uptake, metabolism and biologic effects of retinol delivered
to human keratinocytes either free or bound to serum
retinol-binding protein. J Nutr. 1993 Feb;123(2
Suppl):356-61.
Batova A, Danielpour D, Pirisi L, Creek KE. Retinoic acid
induces secretion of latent transforming growth factor beta
1 and beta 2 in normal and human papillomavirus type
16-immortalized human keratinocytes. Cell Growth Differ.
1992 Nov;3(11):763-72.
Morre DJ, Morre DM, Paulik M, Batova A, Broome AM, Pirisi L,
Creek KE. Retinoic acid and calcitriol inhibition of growth
and NADH oxidase of normal and immortalized human
keratinocytes. Biochim Biophys Acta. 1992 Apr
7;1134(3):217-22.
Pirisi L, Batova A, Jenkins GR, Hodam JR, Creek KE.
Increased sensitivity of human keratinocytes immortalized by
human papillomavirus type 16 DNA to growth control by
retinoids. Cancer Res. 1992 Jan 1;52(1):187-93.
Hodam JR, St Hilaire P, Creek KE. Comparison of the rate of
uptake and biologic effects of retinol added to human
keratinocytes either directly to the culture medium or bound
to serum retinol-binding protein. J Invest Dermatol. 1991
Aug;97(2):298-304.
Shankar S, Creek KE, De Luca LM. The effect of the
progression of vitamin A deficiency on glucose, galactose
and mannose incorporation into sugar phosphates and sugar
nucleotides in hamster liver. J Nutr. 1990
Apr;120(4):361-74.
Rimoldi D, Creek KE, De Luca LM. Reduced mannose
incorporation into GDP-mannose and dolichol-linked
intermediates of N-glycosylation in hamster liver during
vitamin A deficiency. Mol Cell Biochem. 1990 Mar
27;93(2):129-40.
Sinha R, Creek KE, Silverman-Jones C, De Luca LM. Retinoic
acid treatment of fibroblasts causes a rapid decrease in
[3H]inositol uptake. Exp Cell Res. 1989 Apr;181(2):385-99.
Creek KE, Silverman-Jones CS, De Luca LM. Comparison of the
uptake and metabolism of retinol delivered to primary mouse
keratinocytes either free or bound to rat serum
retinol-binding protein. J Invest Dermatol. 1989
Feb;92(2):283-9.
Pirisi L, Creek KE, Doniger J, DiPaolo JA. Continuous cell
lines with altered growth and differentiation properties
originate after transfection of human keratinocytes with
human papillomavirus type 16 DNA. Carcinogenesis. 1988
Sep;9(9):1573-9.
Nolan CM, Creek KE, Grubb JH, Sly WS. Antibody to the
phosphomannosyl receptor inhibits recycling of receptor in
fibroblasts. J Cell Biochem. 1987 Oct;35(2):137-51.
Creek KE, Shankar S, De Luca LM. In vivo formation of
tritium-labeled lactic acid from [2-3H]mannose or
[15-3H]retinol by hamster intestinal epithelial cells. Arch
Biochem Biophys. 1987 May 1;254(2):482-90.
Minnifield N, Creek KE, Navas P, Morre DJ. Involvement of
cis and trans Golgi apparatus elements in the intracellular
sorting and targeting of acid hydrolases to lysosomes. Eur J
Cell Biol. 1986 Oct;42(1):92-100.
Creek KE, Rimoldi D, Clifford AJ, Silverman-Jones CS, De
Luca LM. Mannosylation of endogenous and exogenous
phosphatidic acid by liver microsomal membranes. Formation
of phosphatidylmannose. J Biol Chem. 1986 Mar
15;261(8):3490-500.
Creek KE, Rimoldi D, Brugh-Collins M, De Luca LM. Enzymatic
synthesis and separation of retinyl phosphate mannose and
dolichyl phosphate mannose by anion-exchange
high-performance liquid chromatography. Methods Enzymol.
1986;123:61-8.
De Luca LM, Creek KE. Vitamin A and the liver. Prog Liver
Dis. 1986;8:81-98.
Clifford AJ, Silverman-Jones CS, Creek KE, De Luca LM,
Tondeur Y. Fast atom bombardment and collisional activation
mass spectrometry of retinyl phosphate mannose synthesized
by liver membranes. Biomed Mass Spectrom. 1985
May;12(5):221-7.
Creek KE, Rimoldi D, Silverman-Jones CS, De Luca LM.
Synthesis of retinyl phosphate mannose in vitro. Non-enzymic
breakdown and reversibility. Biochem J. 1985 May
1;227(3):695-703.
Creek KE, Walter VP, Evers D, Yeo E, Elliott WL, Heinstein
PF, Morre DM, Morre DJ. Sialoglycoconjugate changes during
2-acetylaminofluorene-induced hepatocarcinogenesis in the
rat. Biochim Biophys Acta. 1984 Apr 18;793(2):133-40.
Strisciuglio P, Creek KE, Sly WS. Complementation, cross
correction, and drug correction studies of combined
beta-galactosidase neuraminidase deficiency in human
fibroblasts. Pediatr Res. 1984 Feb;18(2):167-71.
Elliott WL, Sawick DP, Creek KE, Deutscher SL, Quinn JF, Yeo
E, Webb WR, Morre DM, Harrington DD, Heinstein PF, et al.
Early biochemical alterations induced by
2-acetylaminofluorene in rat liver. Int J Biochem.
1984;16(9):947-56.
Creek KE, Sly WS. Biosynthesis and turnover of the
phosphomannosyl receptor in human fibroblasts. Biochem J.
1983 Aug 15;214(2):353-60.
Deutscher SL, Creek KE, Merion M, Hirschberg CB.
Subfractionation of rat liver Golgi apparatus: separation of
enzyme activities involved in the biosynthesis of the
phosphomannosyl recognition marker in lysosomal enzymes.
Proc Natl Acad Sci U S A. 1983 Jul;80(13):3938-42.
Creek KE, Morre DJ, Silverman-Jones CS, Shidoji Y, De Luca
LM. Mannosyl carrier functions of retinyl phosphate and
dolichyl phosphate in rat liver endoplasmic reticulum.
Biochem J. 1983 Feb 15;210(2):541-7.
Fischer HD, Creek KE, Strisciuglio P, Sly WS. Comparative
kinetics of phosphomannosyl receptor-mediated pinocytosis of
fibroblast secretion acid hydrolases and glycopeptides
prepared from them. J Cell Biochem. 1983;22(2):69-86.
Creek KE, Fischer HD, Sly WS. Determinants in the uptake of
lysosomal enzymes by cultured fibroblasts. Methods Enzymol.
1983;98:290-300.
Creek KE, Sly WS. Adsorptive pinocytosis of phosphorylated
oligosaccharides by human fibroblasts. J Biol Chem. 1982 Sep
10;257(17):9931-7.
Fischer HD, Creek KE, Sly WS. Binding of phosphorylated
oligosaccharides to immobilized phosphomannosyl receptors. J
Biol Chem. 1982 Sep 10;257(17):9938-43.
Deutscher SL, Creek KE, Morre DJ. Inhibition of Golgi
apparatus-mediated secretion by cinnamic acid derivatives.
Eur J Cell Biol. 1981 Oct;25(2):324-30.
Creek KE, Morre DJ. Translocation of cytidine
5'-monophosphosialic acid across Golgi apparatus membranes.
Biochim Biophys Acta. 1981 May 6;643(2):292-305.
Morre DJ, Creek KE, Morre DM, Richardson CL. Glycosylation
reactions and tumor establishment: modulation by vitamin A.
Ann N Y Acad Sci. 1981 Feb 27;359:367-82.
Creek KE, Weisman DC, Morre DJ. The subcellular distribution
of cytidine 5'-monophosphosialic acid synthetase in rat
liver. Eur J Cell Biol. 1980 Dec;23(1):157-65.
Creek KE, Morre DJ. Effects of retinol and retinol palmitate
on glycolipid and glycoprotein galactosyltransferase
activities of rat liver plasma membranes. Biochem Biophys
Res Commun. 1980 Aug 29;95(4):1775-80.
For recent abstracts, click here
|
